REVE TECHNOLOGIES, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-08-23: Form 8-K; Period of report 2016-08-22; Description 7.01 Regulation FD Disclosure; 8.01 Other Events; Details 7.01.
- 2016-06-03: Form 8-K; Period of report 2016-04-25; Description 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 3.02.
- 2016-04-25: Form 8-K; Period of report 2016-02-19; Description 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 1.01.
- 2016-01-14: Form 8-K; Period of report 2015-11-23; Description 3.02 Unregistered Sales of Equity Securities; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Details 3.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2016-08-23 | 8-K | 2016-08-22 | 7.01 Regulation FD Disclosure; 8.01 Other Events | 7.01 On August 19, 2016, Cantech Holding, Inc., or the Company, announced that announced it has received a Letter of Intent which proposes a business collaboration with newly formed Institute of Medicine of the conservation ZELOR S.A.P.I., located in Tijuana B.C. Mexico (“Zelor”). 8.01 This Current Report may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act and Section 21E of the Exchange Act. | form8k.htm |
| 2016-06-03 | 8-K | 2016-04-25 | 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 3.02 During the period commencing April 24, 2016 through June 1, 2016, the Company issued 2,285,409,838 common shares to reduce debt on certain convertible promissory notes. 5.02 The information set forth and incorporated by reference in Item 3.02 and 5.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02. 5.03 RESOLVED, the name of the corporation shall be immediately changed from REVE TECHNOLOGIES, INC. to CANTECH HOLDING, INC. 8.01 A new website is currently under construction for Cantech Holding, Inc. The new website address when completed will be located at www.cantechholding.com. | form8k.htm |
| 2016-04-25 | 8-K | 2016-02-19 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 1.01 Effective April 19, 2016 the Registrant and certain preferred shareholders of the Registrant entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with Canteck Pharma, Inc., a Delaware corporation (“Canteck” or“CKPH”) and certain majority shareholders of CKPH. 3.02 On April 19, 2016, the Company issued 667,000 shares of Series B Voting Preferred Stock to Canteck Pharma, Inc. representing 66.7% of the total issued and outstanding shares of the Company’s Series B Voting Preferred Stock. 5.01 The information set forth and incorporated by reference in Item 3.02 of this Current Report on Form 8-K is incorporated by reference into this Item 5.01. 5.02 The information set forth and incorporated by reference in Item 3.02 and 5.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02. 5.03 The information set forth and incorporated by reference in 3.02, 5.01, and 5.02 of this Current Report on Form 8-K is incorporated by reference into this Item 5.03. 8.01 Effective April 19, 2016 the Registrant and certain preferred shareholders of the Registrant entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with Canteck Pharma, Inc., a Delaware corporation (“Canteck” or“CKPH”) and certain majority shareholders of CKPH. | form8k.htm |
| 2016-01-14 | 8-K | 2015-11-23 | 3.02 Unregistered Sales of Equity Securities; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3.02 During the period commencing November 23, 2015 through January 14, 2016, the Company issued approximately 399,514,779 common shares to reduce debt on certain convertible promissory notes. 5.03 On November 29, 2015, the Board of Directors of Reve Technologies, Inc. (the “Company”) approved by its consent to amend the Company’s Articles of Incorporation to increase the authorized capital stock which become effective December 28, 2015. | form8k.htm |
| 2015-11-03 | 8-K | 2015-10-30 | 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3.02 On November 1, 2015, the Company issued 500,000 shares of Series B Voting Preferred Stock to Dennis Alexander representing 50% of the total issued and outstanding shares of the Company’s Series B Voting Preferred Stock. 5.01 The information set forth and incorporated by reference in Item 3.02 of this Current Report on Form 8-K is incorporated by reference into this Item 5.01. 5.02 The information set forth and incorporated by reference in Item 3.02 and 5.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02. 5.03 The information set forth and incorporated by reference in 3.02, 5.01, and 5.02 of this Current Report on Form 8-K is incorporated by reference into this Item 5.03. | form8k.htm |
| 2015-10-21 | 8-K | 2015-10-21 | 8.01 Other Events | 8.01 The Registrants cover page to its Original Reports, as described in the table above, contained an incorrect selection of shell status as defined in Rule 12b-2. | form8k.htm |
| 2015-08-07 | 8-K | 2015-07-30 | 4.01 Changes in Registrant's Certifying Accountant; 7.01 Regulation FD Disclosure | 4.01 In a Form 8-K filed on July 28, 2015, Reve Technologies, Inc. (“Reve,” the “Company,” “we,” “our,” and “us”) announced that a change of control had taken place as a result of the resignation of the sole officer and director. | form8k.htm |
| 2015-07-28 | 8-K | 2015-07-21 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant | 1.01 On July 17, 2015, Reve Technologies, Inc. entered into a material definitive agreement with Mr. Tamio Stehrenberger wherein Mr. Stehrenberger sold his controlling interest in Reve Technologies, Inc. back to the Company for the total price of $50,000. 3.02 The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. 5.01 The information set forth and incorporated by reference in Items 1.01 and 3.02 of this Current Report on Form 8-K is incorporated by reference into this Item 5.01. | form8k.htm |
| 2015-02-03 | 8-K | 2014-12-17 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 3.02 The disclosures in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. | reve_8k.htm |
| 2015-01-09 | 8-K | 2014-12-03 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 3.02 The disclosures in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. | reve_8k.htm |
| 2014-12-15 | 8-K/A | 2014-12-10 | 8.01 Other Events | 8.01 This Form 8-K/A is being filed as an amendment (the “Amendment”) to the Current Report on Form 8-K filed by Rêve Technologies, Inc. (the “Company”) with the U.S. Securities and Exchange Commission ("SEC") on December 11, 2014 (the “Original Filing”). | reve_8ka.htm |
| 2014-12-11 | 8-K | 2014-12-10 | 8.01 Other Events | 8.01 The Company was never a “shell issuer,” as defined in Rule 144(i)(1), promulgated under the Securities Act. | reve_8k.htm |
| 2014-11-12 | 8-K | 2014-09-23 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On September 23, 2014, Rêve Technologies, Inc. (the “Company”) completed the assignment of the assets of MatchTrade, Inc. (MatchTrade) and OnTheCurb, LLC (“OnTheCurb”) to the Company. | reve_8k.htm |
| 2013-11-05 | 8-K | 2013-08-30 | 8.01 Other Events | 8.01 On August 30, 2013, the Board of Directors of Bassline Productions, Inc. (the “Company”) agreed to, and authorized the cancellation of 38,134,399 shares of the Company’s common stock, of which 33,369,399 of the cancelled shares being owned by management or parties affiliated therewith Shares outstanding after the cancellation of the shares will be approximately 36,880,601. | bssp-20131105_8k.htm |
| 2013-06-19 | 8-K | 2013-03-07 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | bass-8k20130619.htm |
| 2013-06-13 | 8-K | 2013-02-07 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | bass-8k20130613.htm |
| 2013-05-14 | 8-K | 2013-05-10 | 3.02 Unregistered Sales of Equity Securities | 3.02 On March 10, 2013 the board of directors approved the issuance of a dividend to the corporations current shareholders through which such shareholders shall receive 2 shares of common stock for each share of common stock held as of May 10, 2013. | bassline-8k20130513.htm |
| 2013-04-03 | 8-K | 2013-04-03 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | bassline_8k-20130403.htm |
| 2013-01-14 | 8-K | 2013-01-02 | 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.01 On January 2, 2013, 2011, Pamela Elliot ( the “Seller”) who is the record or beneficial owner of a total of Nineteen Million Nine Hundred Ninety Nine Thousand Eight Hundred (19,999,800) shares of common stock (the “Common Shares”) of Bassline Productions, Inc., a Nevada corporation (the “Company”), entered into a stock purchase agreement (the “Stock Purchase Agreement”) with Taanen, L.P. (the “Purchaser”) for the sale and purchase of the Common Shares. 5.02 On January 3, 2013, Lisa Rubin, resigned from her positions as the Company’s Secretary and Treasurer. | bssp8k.htm |
| 2012-12-10 | 8-K | 2012-12-07 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On December 7, 2012, Randi Lorenzo submitted her letter of resignation from her position as President, CEO and Director of the Registrant, effective immediately. | bssp8k.htm |